Tender detail
Open House pharmaceutical discount agreements for the active substance Olanzapine, without fixed oral dosage forms, ATC N05AH03
Summary
The tender concerns non-exclusive discount agreements for medicines containing the active substance olanzapine, using an Open House model, during the period 01 November 2026 to 31 October 2028. Contracts will be concluded as needed under this Open House model; medicines intended for children are excluded according to applicable regulations.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.